GE HealthCare Technologies Inc. announced the presentation of findings from a large real-world evidence study on its End-tidal Control anesthesia delivery software, conducted at the University of Michigan. The results, which demonstrated environmental and clinical benefits of the software, were presented at ANESTHESIOLOGY 2025, held from October 10-14 in San Antonio, Texas. The study showed a 45.6% reduction in anesthetic agent usage, resulting in lower greenhouse gas emissions and costs. Additional research on End-tidal Control was also presented at the meeting, highlighting its applicability across various clinical settings. The University of Michigan study was funded by GE HealthCare.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. GE HealthCare Technologies Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 20251010547923) on October 13, 2025, and is solely responsible for the information contained therein.